Tyrosine Kinase Inhibitors Chemotherapy CD Protein Inhibitors Immunotherapy Interleukins DNA Epigenetics Kinase Inhibitors Serine-Threonine Kinase Inhibitors Other | Diffuse Large B Cell Lymphoma | Waldenstrom Macroglobulinemia | Lymphoma | Marginal Zone Lymphoma |
---|---|---|---|---|
ibrutinib | ||||
zanubrutinib | ||||
rituximab + lenalidomide + acalabrutinib | ||||
orelabrutinib | ||||
methotrexate | ||||
rituximab + orelabrutinib | ||||
pomalidomide | ||||
inotuzumab ozogamicin | ||||
rituximab | ||||
pacritinib | ||||
rituximab + KT-413 | ||||
BTK inhibitor | ||||
BTM-3566 | ||||
BTK inhibitor + KT-413 | ||||
KT-413 |